Sign inJoin waitlistJoin the waitlist

Laila Gharzai

Assistant Professor, Radiation Oncology · McGaw Medical Center of Northwestern University

Credentials: · · · · ·

History

McGaw Medical Center of Northwestern University
Present
McGaw Medical Center of Northwestern University
Present

University of Michigan Health
2017–2021
Creighton University School of Medicine
2016–2017
Univ of Nebraska Coll of Med
2012–2016

Research

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
Systematic review or meta-analysis · International journal of radiation oncology · 2019 · 297 citations
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Systematic review or meta-analysis · The Lancet Oncology · 2021 · First of 25 authors · 97 citations
Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer
JAMA Oncology · 2020 · 89 citations

MM
Michelle Mierzwa
16 papers
Reshma Jagsi
13 papers
Leila Mady
11 papers
Katelyn Stepan
9 papers
EJ
Elizabeth Jaworski
8 papers · 8 as a resident
Jennifer Shah
8 papers
Daniel Spratt
7 papers
Will Jackson
7 papers · 3 as a resident
Alexis Larson
5 papers
AE
Avraham Eisbruch
5 papers
David Cella
5 papers
Gelareh Sadigh
5 papers

Clinical trials

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
Principal investigator · Recruiting · Phase 2
Northwestern University
2025–2031
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Site PI · Recruiting · Phase 3
NRG Oncology
2026–2040
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2030
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Site PI · Recruiting · Phase 2
NRG Oncology
2025–2032